Agios Pharma (AGIO) Reports Q2 Loss of $1.47/Share

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.47), versus ($0.85) reported last year. Revenue for the quarter came in at $6.98 million, versus $13.22 million reported last year.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c